Tandem Diabetes Care, Inc.
TNDM
$19.14
$0.965.28%
| 12/31/2024 | 09/30/2024 | ||||
|---|---|---|---|---|---|
| Revenue | 15.85% | 9.94% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | 15.85% | 9.94% | |||
| Cost of Revenue | 4.92% | 9.35% | |||
| Gross Profit | 26.31% | 10.51% | |||
| SG&A Expenses | 6.22% | 5.73% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 4.88% | 6.88% | |||
| Operating Income | 97.77% | 15.21% | |||
| Income Before Tax | 100.07% | 23.97% | |||
| Income Tax Expenses | -216.01% | -40.52% | |||
| Earnings from Continuing Operations | 103.25% | 24.54% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | 103.25% | 24.54% | |||
| EBIT | 97.77% | 15.21% | |||
| EBITDA | 116.74% | 17.94% | |||
| EPS Basic | 103.21% | 25.16% | |||
| Normalized Basic EPS | 108.85% | 19.15% | |||
| EPS Diluted | 103.21% | 25.16% | |||
| Normalized Diluted EPS | 108.81% | 19.15% | |||
| Average Basic Shares Outstanding | 0.61% | 0.84% | |||
| Average Diluted Shares Outstanding | 0.94% | 0.84% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||
